University Hospitals Seidman Cancer Center Provides Personalized Care for Patients with Appendix Cancer
Appendix cancer is rare and is diagnosed in less than 1,000 people in the U.S. each year. At UH Seidman Cancer Center, we use leading-edge diagnostics and cancer treatment innovations such as specialized surgery techniques, chemotherapy and targeted therapies to treat appendix cancer. With groundbreaking clinical trials, UH Seidman Cancer Center’s physicians have established many innovations in successful treatment of appendix cancer. We will help patients through each step of cancer care, providing a compassionate approach that keeps quality of life a part of our care decisions.
Nationally Recognized Cancer Program
UH Seidman Cancer Center is part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine, which is one of an elite group of 41 comprehensive cancer hospitals nationwide. Our team of fellowship-trained oncologists and surgeons offers leading-edge innovations in diagnostics and high-tech surgical techniques. Our experts include:
- Colorectal surgeons
- Hepatobiliary surgeons
- Medical oncologists
- Oncology nurses
- Radiation oncologists
- Social workers
Team of Experts Guide Cancer Care Decisions
UH Seidman Cancer Center is a nationally recognized cancer program with expertise in both routine and very complex care. We offer patients a multidisciplinary team approach, which means all our cancer doctors, nurses and support staff coordinate your care. Our multidisciplinary team conducts a disease-specific tumor board review each week for a more focused and comprehensive approach to treatment. Tumor board review involves a meeting where every patient’s case is read and discussed among an entire team of national experts to guide cancer care decisions. This review process ensures that all realistic treatment options are considered.
Some of our advanced treatments include:
Our surgeons can remove tumors that previously would have been considered untreatable. They achieve this through the use of preoperative chemotherapy and radiation.
Cancer Clinical Trials
UH Seidman Cancer Center is a leading cancer research center providing many available clinical trials for cancer patients.
- A study to evaluate the effect of NKTR-102 on the QT/QTc interval in patients with advanced or metastatic solid tumors. Learn more.
- Studying the safety and best dose of a cancer drug for people with solid tumors that have spread to other parts of the body. Learn more.